NOSOCOMIAL INFECTIONS: AN OVERVIEW
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2014, Vol 5, Issue 1
Abstract
Nosocomial infections (NI) are one of the major complications for the healthcare professionals to tackle. It is a major source of morbidity, mortality, and also monetary burden on patients. The main risk factors for NI’s are related to both hospitals and patients. Maximum number of NI’s is known to be caused by Staphylococcus aureus including MRSA and VRSA, Pseudomonas aeruginosa, Acinetobacter baumannii, Coagulase negative staphylococci to name but few. Similarly the major sites of infections are respiratory tract, urinary tract, surgical site and blood stream. Certain strategies are needed to be followed by the hospital authority to reduce the incidence of NI’s, such as better surveillance system and infection control, proper use of antibiotics, hand hygiene and many more. The treatment options for NI’s vary depending upon the site of infection and severity which includes combination antibiotic therapy. Although NI’s are hazardous they can be resolved by following the prevention and treatment strategies.
Authors and Affiliations
Maazuddin Mohammed, Arshad Mohammed, Misba Mirza, Azizullah Ghori
Keywords
Related Articles
- EP ID EP141705
- DOI 10.7897/2230-8407.050102
- Views 82
- Downloads 0
FORMULATION AND EVALUTION OF ORALLY DISINTEGRATING TABLETS OF MECLIZINE HYDROCHLORIDE
The objective of necessary work to develop meclizine HCl fast disintegrating tablet using different disintegrant which would disintegrate tablet rapidly in oral cavity. Nine batches of meclizine HCl orally disintegrating...
FORMULATION DEVELOPMENT AND EVALUATION OF CARVEDILOL TABLET
The aim of the study was to develop a formulation of Carvedilol 25 mg tablet that is equivalent to the reference product using similar excipients to match the in-vitro dissolution profile. A compressed coated tablet was...
PHYTOCHEMICAL CHARACTERIZATION OF AN ENDEMIC PLANT USED AS FOODSTUFF IN TURKEY: CENTAUREA URVILLEI SUBSP. STEPPOSA AND ITS ANTIOXIDANT PROPERTIES
This study was focused on the analysis of the phenolic content, fatty acid composition, volatile compounds and antioxidant activity of methanol extract from Centaurea urvillei subsp. stepposa. The antioxidant capacity we...
RNAi THERAPEUTICS
RNA interference (RNAi) was discovered less than a decade ago and already there are human clinical trials in progress or planned. A major advantage of RNAi versus other antisense based approaches for therapeutic applicat...
DEVELOPMENT OF QUALITY STANDARDS OF BERBERIS ARISTATA STEM BARK
Berberis aristata is an important medicinal plant of family Berberidaceae. It is commonly known as Zarishk and Daruhaldi. It is mainly used for the treatment piles, liver diseases and diabetes. As the herb is used widely...